Radiation Therapy or Temozolomide in Treating Patients With Gliomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brigitta Baumert, MD, PhD
Maastricht University Medical Center
Study Chair - Roger Stupp, MD
Centre Hospitalier Universitaire Vaudois
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
89 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prince of Wales Private Hospital
Randwick, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Sydney Cancer Centre at Royal Prince Alfred Hospital
Sydney, New South Wales, Australia
- Calvary Mater Newcastle
Waratah, New South Wales, Australia
- Princess Alexandra Hospital
Brisbane, Queensland, Australia
- Royal Brisbane and Women'S Hospital
Brisbane, Queensland, Australia
- Mater Adult Hospital
South Brisbane, Queensland, Australia
- Peter Maccallum Cancer Centre
East Melbourne, Victoria, Australia
- Austin and Repatriation Medical Centre
Heidelberg West, Victoria, Australia
- Alfred Hospital
Prahran, Victoria, Australia
- Sir Charles Gairdner Hospital - Nedlands
Nedlands, Western Australia, Australia
- Liverpool Hospital
Liverpool, Australia
- Medical University Vienna - General Hospital Akh
Vienna, Austria
- Hopital Universitaire Erasme
Brussels, Belgium
- Universitair Ziekenhuis Brussel
Brussels, Belgium
- U.Z. Leuven - Campus Gasthuisberg
Leuven, Belgium
- Tom Baker Cancer Centre - Calgary
Calgary, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
- Edmond Odette Cancer Centre at Sunnybrook
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Hopital Notre-Dame Du Chum
Montreal, Quebec, Canada
- Mcgill University Health Centre - Gerald Bronfman Centre - Dept of Oncology
Montreal, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Bc Cancer Agency
Vancouver, Canada
- National Cancer Institute of Egypt
Cairo, Egypt
- Chu de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre
Bordeaux, France
- Institut Bergonie
Bordeaux, France
- Chu de Grenoble - Hopital de la Tronche
Grenoble, France
- Chu de la Timone
Marseille, France
- Centre Regional Rene Gauducheau
Nantes-Saint Herblain, France
- Assistance Publique - Hopitaux de Paris - la Pitie Salpetriere
Paris, France
- Centre Eugene Marquis
Rennes, France
- Centre Paul Strauss
Strasbourg, France
- Institut Claudius Regaud
Toulouse, France
- Gustave Roussy
Villejuif, France
- Universitatsklinikum Heidelberg
Heidelberg, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2005
- Primary completion
- 31 Aug 2013
- Completion
- 31 May 2014
- Last update posted
- 12 Oct 2016
- Registered enrollment
- 709
- Registry id
- NCT00182819
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.